FdaApplication

ANDA 214476

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBIOCON PHARMA LTD
application_typeANDA
approval_date2022-02-04

Products (1)

ProductActive ingredientStrengthDosage form
POSACONAZOLEPOSACONAZOLE100MGTABLET, DELAYED RELEASE;ORAL

1 product